Blog

  • Weight loss drugs can make you regain pounds? Natural, sustainable alternatives to Ozempic and Mounjaro

    Weight loss drugs can make you regain pounds? Natural, sustainable alternatives to Ozempic and Mounjaro

    Rebound Weight Gain: What Really Happens When You Quit Ozempic and Mounjaro (Image: iStock)

    For millions chasing quick-fix weight loss, diabetes drugs like Ozempic and Mounjaro have become near-mythical. Marketed as “miracle injections” that…

    Continue Reading

  • The journey of Number 1 Energy Drink and rapper Den inspires passion

    The journey of Number 1 Energy Drink and rapper Den inspires passion

    Amid the bright stage lights, pounding bass, and the enthusiastic cheers of the audience, Den appears with the limited-edition Number 1 bottle in vivid yellow, which shines like the flames of passion. The release of Number 1 and Den’s commercial…

    Continue Reading

  • Keys to the Game: Celtics 122, Pelicans 90 – NBA

    Keys to the Game: Celtics 122, Pelicans 90 – NBA

    1. Keys to the Game: Celtics 122, Pelicans 90  NBA
    2. Celtics rout Pelicans for first win of season  Reuters
    3. NO.pelsceltics.10272025469.jpg  The Advocate
    4. Celtics Pelicans Basketball  couriernews.com
    5. Boston Celtics Seek First Win Against Zion-Led Pelicans…

    Continue Reading

  • Sky Metals Limited’s (ASX:SKY) Shift From Loss To Profit

    Sky Metals Limited’s (ASX:SKY) Shift From Loss To Profit

    Sky Metals Limited (ASX:SKY) is possibly approaching a major achievement in its business, so we would like to shine some light on the company. Sky Metals Limited engages in the exploration and development of mineral resources in Australia. On 30 June 2025, the AU$60m market-cap company posted a loss of AU$3.2m for its most recent financial year. As path to profitability is the topic on Sky Metals’ investors mind, we’ve decided to gauge market sentiment. We’ve put together a brief outline of industry analyst expectations for the company, its year of breakeven and its implied growth rate.

    AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part – they are all under $10bn in marketcap – there is still time to get in early.

    Sky Metals is bordering on breakeven, according to some Australian Metals and Mining analysts. They anticipate the company to incur a final loss in 2027, before generating positive profits of AU$4.0m in 2028. So, the company is predicted to breakeven approximately 3 years from today. How fast will the company have to grow each year in order to reach the breakeven point by 2028? Working backwards from analyst estimates, it turns out that they expect the company to grow 88% year-on-year, on average, which signals high confidence from analysts. Should the business grow at a slower rate, it will become profitable at a later date than expected.

    ASX:SKY Earnings Per Share Growth October 28th 2025

    Given this is a high-level overview, we won’t go into details of Sky Metals’ upcoming projects, though, take into account that by and large metals and mining companies, depending on the stage of operation and metals mined, have irregular periods of cash flow. This means, large upcoming growth rates are not abnormal as the company is beginning to reap the benefits of earlier investments.

    Check out our latest analysis for Sky Metals

    One thing we’d like to point out is that Sky Metals has no debt on its balance sheet, which is rare for a loss-making metals and mining company, which usually has a high level of debt relative to its equity. This means that the company has been operating purely on its equity investment and has no debt burden. This aspect reduces the risk around investing in the loss-making company.

    There are key fundamentals of Sky Metals which are not covered in this article, but we must stress again that this is merely a basic overview. For a more comprehensive look at Sky Metals, take a look at Sky Metals’ company page on Simply Wall St. We’ve also compiled a list of pertinent aspects you should further examine:

    Continue Reading

  • Bananas could be ruining your smoothie’s health benefits

    Bananas could be ruining your smoothie’s health benefits

    Smoothies are a quick and delicious way to load up on fruits and vegetables, but some ingredient combinations may not be as healthy as they seem. Scientists from the University of California, Davis, discovered that the types of fruits blended…

    Continue Reading

  • Bananas could be ruining your smoothie’s health benefits

    Bananas could be ruining your smoothie’s health benefits

    Smoothies are a quick and delicious way to load up on fruits and vegetables, but some ingredient combinations may not be as healthy as they seem. Scientists from the University of California, Davis, discovered that the types of fruits blended…

    Continue Reading

  • Celebrating Three Finalist Recognitions at MIPIM Asia 2025 Awards

    Celebrating Three Finalist Recognitions at MIPIM Asia 2025 Awards

    We have exciting news to share. Three of our landmark projects have been selected as finalists at the prestigious MIPIM Asia 2025 Awards, each competing in distinct categories. This recognition reflects our unwavering commitment to placemaking across Asia.


    Our Finalist Projects:

    18 Cross, SingaporeBest Urban Regeneration Project
    This transformation of the former Cross Street Exchange has created a thriving destination in Singapore’s CBD. The14,000 sqm development seamlessly merges a contemporary 15-storey Grade A office tower with heritage shophouses, achieving both Green Mark and WELL Platinum certifications. With its biophilic design, energy-efficient systems, and EV infrastructure, 18 Cross exemplifies how thoughtful regeneration can honour the past while building for the future.

    Taichung D‑ONE, TaiwanBest New Mega Development Project
    Taichung D‑ONE is a visionary 47,000 sqm transit-oriented development that weaves together landscape, architecture, and cultural identity. Positioned at a strategic transportation nexus connecting highway, metro, and high-speed rail, Taichung D‑ONE is set to become a civic-commercial landmark. Beyond its department store and conference facilities, themed zones throughout the project create a more diverse and engaging urban destination.

    Wuhan Alibaba Centre, ChinaBest Mixed-Use Project
    Our latest collaboration with Alibaba brings 450,000sqm of smart, integrated space to central China. The development features twin towers (272.5m and 173m) with a six-storey retail podium, all inspired by the traditional Kongming lock” with its intricate interlocking forms. This dynamic hub fuses talent, entrepreneurship, commerce, and lifestyle, creating versatile public spaces designed for the modern digital economy.

    Winners will be revealed at the Gala Dinner on December 4th at Rosewood Hong Kong, coinciding with the MIPIM Asia Summit on December 3rd-4th.

    We’re honoured to be recognised alongside Asia’s finest developments and look forward to celebrating this milestone with our clients, partners, and the wider community.

    Discover the full list of finalists: https://​awards​.mip​im​-asia​.com/​m​i​p​i​m​a​s​i​a​a​w​a​r​d​s​2​0​2​5​/​e​n​/​p​a​g​e​/​s​h​o​r​t​l​i​s​t​e​d​-​w​i​n​n​e​r​s​-2025

    Continue Reading

  • Asiana Airlines 35th Anniversary: 10% Off Japan–Korea Economy Fares (Oct 14–Nov 30)

    Asiana Airlines 35th Anniversary: 10% Off Japan–Korea Economy Fares (Oct 14–Nov 30)

    Asiana Airlines is running a 35th Anniversary of Japan–Korea Routes Promotion from October 14 through November 30.

    Round-trip and one-way economy-class tickets from Japan to South Korea are 10% off. Fuel surcharges and…

    Continue Reading

  • Middle Eastern Dividend Stocks Featuring Gulf Medical Projects Company (PJSC) And Two More

    Middle Eastern Dividend Stocks Featuring Gulf Medical Projects Company (PJSC) And Two More

    As Gulf markets navigate mixed performances amid easing U.S.-China trade tensions and tepid earnings, investors are closely watching the impacts on regional indices. In this environment, dividend stocks can offer a measure of stability and income potential, making them an attractive option for those seeking to balance risk with steady returns.

    Name

    Dividend Yield

    Dividend Rating

    Turkiye Garanti Bankasi (IBSE:GARAN)

    3.41%

    ★★★★★☆

    Saudi Telecom (SASE:7010)

    9.39%

    ★★★★★☆

    Saudi Awwal Bank (SASE:1060)

    6.23%

    ★★★★★☆

    Riyad Bank (SASE:1010)

    6.52%

    ★★★★★☆

    National General Insurance (P.J.S.C.) (DFM:NGI)

    7.54%

    ★★★★★☆

    National Bank of Ras Al-Khaimah (P.S.C.) (ADX:RAKBANK)

    6.41%

    ★★★★★☆

    Emaar Properties PJSC (DFM:EMAAR)

    6.94%

    ★★★★★☆

    Computer Direct Group (TASE:CMDR)

    8.09%

    ★★★★★☆

    Commercial Bank of Dubai PSC (DFM:CBD)

    5.34%

    ★★★★★☆

    Banque Saudi Fransi (SASE:1050)

    6.18%

    ★★★★★☆

    Click here to see the full list of 68 stocks from our Top Middle Eastern Dividend Stocks screener.

    We’re going to check out a few of the best picks from our screener tool.

    Simply Wall St Dividend Rating: ★★★★☆☆

    Overview: Gulf Medical Projects Company (PJSC) operates hospitals in the United Arab Emirates and has a market cap of AED 1.44 billion.

    Operations: Gulf Medical Projects Company (PJSC) generates revenue primarily from Health Services & Others, amounting to AED 711.55 million, and Investments, contributing AED 50.66 million.

    Dividend Yield: 7.3%

    Gulf Medical Projects Company offers a high dividend yield of 7.28%, placing it among the top 25% in the AE market. However, its dividends are not well covered by earnings, with a payout ratio of 106.2%. Despite recent earnings growth and cash flow coverage at an 84.6% cash payout ratio, dividend payments have been volatile over the past decade. The stock trades significantly below its estimated fair value but has experienced high price volatility recently.

    ADX:GMPC Dividend History as at Oct 2025

    Simply Wall St Dividend Rating: ★★★★☆☆

    Overview: Delek Group Ltd. is an energy company involved in the exploration, development, production, and marketing of oil and gas both in Israel and internationally, with a market cap of ₪15.12 billion.

    Operations: Delek Group’s revenue segments include the development and production of oil and gas assets in the North Sea, generating ₪9.45 billion, and oil and gas exploration and production in Israel and its surroundings, contributing ₪3.36 billion.

    Dividend Yield: 6.2%

    Delek Group’s dividend yield of 6.22% ranks in the top 25% of the IL market, yet its dividends are unreliable and volatile over the past decade. Despite a low cash payout ratio of 26.1%, indicating coverage by cash flows, earnings do not cover dividends due to a high payout ratio of 107.5%. The company’s net income has declined despite increased sales, and it faces significant debt levels while trading below estimated fair value.

    TASE:DLEKG Dividend History as at Oct 2025
    TASE:DLEKG Dividend History as at Oct 2025

    Simply Wall St Dividend Rating: ★★★★☆☆

    Overview: I.D.I. Insurance Company Ltd. offers a range of insurance products and services to both individual and corporate clients in Israel, with a market cap of ₪2.88 billion.

    Operations: I.D.I. Insurance Company Ltd. generates its revenue through the provision of diverse insurance products and services to both individual and corporate clients in Israel.

    Dividend Yield: 6.7%

    I.D.I. Insurance’s dividend yield of 6.74% is among the top 25% in the IL market, but its dividends have been volatile and unreliable over the past decade. The low payout ratio of 35.3% suggests earnings cover dividends, yet a high cash payout ratio of 264.1% indicates insufficient cash flow coverage. Despite recent earnings growth—net income rose to ILS 94.62 million for Q2—the dividend sustainability remains questionable due to these financial constraints.

    TASE:IDIN Dividend History as at Oct 2025
    TASE:IDIN Dividend History as at Oct 2025

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

    Companies discussed in this article include ADX:GMPC TASE:DLEKG and TASE:IDIN.

    This article was originally published by Simply Wall St.

    Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

    Continue Reading

  • Insurance Approvals And Neurosurgical Patients — Dr Vicknes Waran

    Insurance Approvals And Neurosurgical Patients — Dr Vicknes Waran

    I am writing this as a follow-up to your recent survey on insurance approvals for patients undergoing treatment, which was both timely and necessary.

    While that article primarily focused on the…

    Continue Reading